Table 2 Occurrence of contrast nephropathy (several definitions) according to the group of inclusion (placebo or n-acetylcysteine)
Event | Placebo | NAC | P-value |
|---|---|---|---|
(n = 58) | (n = 52) | ||
25% increase of creatinine or cystatin C | 13 (22.4%) | 14 (26.9%) | 0.66 |
25% increase creatinine | 10 (17.2%) | 8 (15.4%) | 0.99 |
25% increase cystatin C | 9 (15.5%) | 9 (17.3%) | 0.99 |
AKIN stage 1 | 11 (19.0%) | 13 (25.0%) | 0.49 |
AKIN all stages | 12 (20.7%) | 13 (25.0%) | 0.65 |